Brief: Crispr Therapeutics AG To Sell About $280 Million Of Its Common Shares

Crispr Therapeutics AG

13/02/2024 15:36

Feb 13 (Reuters) - CRISPR Therapeutics AG  CRSP.BN :
    * INVESTMENT AGREEMENT FOR SALE OF APPROXIMATELY $280
MILLION OF
ITS COMMON SHARES
    * SALE OF SHARES AT A PRICE PER SHARE OF $71.50

Source text for Eikon:  ID:nGNX2xQj7 
Further company coverage:  CRSP.BN 

 ((Reuters.Briefs@thomsonreuters.com;))